Zota Health Care LImited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32

Zota Health Care filed its quarterly statement of deviation under SEBI Regulation 32, covering multiple preferential issues and one Qualified Institutions Placement (QIP). The company raised approximately Rs. 35,000 lakh via QIP at Rs. 1,535 per share in December 2025, plus multiple tranches of preferential issues and convertible warrant conversions dating back to August 2024. The Audit Committee confirmed no deviation or variation in the use of funds — all proceeds from preferential issues were fully utilised against their stated objects (DAVAINDIA project expansion, working capital, and general corporate purposes) as of March 31, 2026. Notably, the QIP proceeds of ~Rs. 34,033 lakh (net of expenses) remain entirely unutilised with zero deployment during the quarter, as the company is still in the early deployment stage against its planned objects (investment in DHML for new COCO stores, working capital, and general corporate purpose).